Dietary fructose reduction improves markers of cardiovascular disease risk in Hispanic-American adolescents with NAFLD

Ran Jin, Jean A. Welsh, Ngoc Anh Le, Jeffrey Holzberg, Puneet Sharma, Diego R Martin, Miriam B. Vos

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Nonalcoholic fatty liver disease (NAFLD) is now thought to be the most common liver disease worldwide. Cardiovascular complications are a leading cause of mortality in NAFLD. Fructose, a common nutrient in the westernized diet, has been reported to be associated with increased cardiovascular risk, but its impact on adolescents with NAFLD is not well understood. We designed a 4-week randomized, controlled, double-blinded beverage intervention study. Twenty-four overweight Hispanic-American adolescents who had hepatic fat >8% on imaging and who were regular consumers of sweet beverages were enrolled and randomized to calorie-matched study-provided fructose only or glucose only beverages. After 4 weeks, there was no significant change in hepatic fat or body weight in either group. In the glucose beverage group there was significantly improved adipose insulin sensitivity, high sensitivity C-reactive protein (hs-CRP), and low-density lipoprotein (LDL) oxidation. These findings demonstrate that reduction of fructose improves several important factors related to cardiovascular disease despite a lack of measurable improvement in hepatic steatosis. Reducing dietary fructose may be an effective intervention to blunt atherosclerosis progression among NAFLD patients and should be evaluated in longer term clinical trials.

Original languageEnglish (US)
Pages (from-to)3187-3201
Number of pages15
JournalNutrients
Volume6
Issue number8
DOIs
StatePublished - Aug 8 2014

Fingerprint

Hispanic Americans
Beverages
fatty liver
Fructose
cardiovascular diseases
fructose
Cardiovascular Diseases
beverages
Liver
Fats
Glucose
LDL Lipoproteins
liver
glucose
C-Reactive Protein
C-reactive protein
Insulin Resistance
Liver Diseases
liver diseases
low density lipoprotein

Keywords

  • Cardiovascular risk
  • Children and adolescents
  • Fructose
  • Hepatic steatosis
  • Nonalcoholic fatty liver disease
  • Obesity
  • Sugar

ASJC Scopus subject areas

  • Food Science

Cite this

Dietary fructose reduction improves markers of cardiovascular disease risk in Hispanic-American adolescents with NAFLD. / Jin, Ran; Welsh, Jean A.; Le, Ngoc Anh; Holzberg, Jeffrey; Sharma, Puneet; Martin, Diego R; Vos, Miriam B.

In: Nutrients, Vol. 6, No. 8, 08.08.2014, p. 3187-3201.

Research output: Contribution to journalArticle

Jin, Ran ; Welsh, Jean A. ; Le, Ngoc Anh ; Holzberg, Jeffrey ; Sharma, Puneet ; Martin, Diego R ; Vos, Miriam B. / Dietary fructose reduction improves markers of cardiovascular disease risk in Hispanic-American adolescents with NAFLD. In: Nutrients. 2014 ; Vol. 6, No. 8. pp. 3187-3201.
@article{02fad371ac614b5d908b0b9964f64da5,
title = "Dietary fructose reduction improves markers of cardiovascular disease risk in Hispanic-American adolescents with NAFLD",
abstract = "Nonalcoholic fatty liver disease (NAFLD) is now thought to be the most common liver disease worldwide. Cardiovascular complications are a leading cause of mortality in NAFLD. Fructose, a common nutrient in the westernized diet, has been reported to be associated with increased cardiovascular risk, but its impact on adolescents with NAFLD is not well understood. We designed a 4-week randomized, controlled, double-blinded beverage intervention study. Twenty-four overweight Hispanic-American adolescents who had hepatic fat >8{\%} on imaging and who were regular consumers of sweet beverages were enrolled and randomized to calorie-matched study-provided fructose only or glucose only beverages. After 4 weeks, there was no significant change in hepatic fat or body weight in either group. In the glucose beverage group there was significantly improved adipose insulin sensitivity, high sensitivity C-reactive protein (hs-CRP), and low-density lipoprotein (LDL) oxidation. These findings demonstrate that reduction of fructose improves several important factors related to cardiovascular disease despite a lack of measurable improvement in hepatic steatosis. Reducing dietary fructose may be an effective intervention to blunt atherosclerosis progression among NAFLD patients and should be evaluated in longer term clinical trials.",
keywords = "Cardiovascular risk, Children and adolescents, Fructose, Hepatic steatosis, Nonalcoholic fatty liver disease, Obesity, Sugar",
author = "Ran Jin and Welsh, {Jean A.} and Le, {Ngoc Anh} and Jeffrey Holzberg and Puneet Sharma and Martin, {Diego R} and Vos, {Miriam B.}",
year = "2014",
month = "8",
day = "8",
doi = "10.3390/nu6083187",
language = "English (US)",
volume = "6",
pages = "3187--3201",
journal = "Nutrients",
issn = "2072-6643",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "8",

}

TY - JOUR

T1 - Dietary fructose reduction improves markers of cardiovascular disease risk in Hispanic-American adolescents with NAFLD

AU - Jin, Ran

AU - Welsh, Jean A.

AU - Le, Ngoc Anh

AU - Holzberg, Jeffrey

AU - Sharma, Puneet

AU - Martin, Diego R

AU - Vos, Miriam B.

PY - 2014/8/8

Y1 - 2014/8/8

N2 - Nonalcoholic fatty liver disease (NAFLD) is now thought to be the most common liver disease worldwide. Cardiovascular complications are a leading cause of mortality in NAFLD. Fructose, a common nutrient in the westernized diet, has been reported to be associated with increased cardiovascular risk, but its impact on adolescents with NAFLD is not well understood. We designed a 4-week randomized, controlled, double-blinded beverage intervention study. Twenty-four overweight Hispanic-American adolescents who had hepatic fat >8% on imaging and who were regular consumers of sweet beverages were enrolled and randomized to calorie-matched study-provided fructose only or glucose only beverages. After 4 weeks, there was no significant change in hepatic fat or body weight in either group. In the glucose beverage group there was significantly improved adipose insulin sensitivity, high sensitivity C-reactive protein (hs-CRP), and low-density lipoprotein (LDL) oxidation. These findings demonstrate that reduction of fructose improves several important factors related to cardiovascular disease despite a lack of measurable improvement in hepatic steatosis. Reducing dietary fructose may be an effective intervention to blunt atherosclerosis progression among NAFLD patients and should be evaluated in longer term clinical trials.

AB - Nonalcoholic fatty liver disease (NAFLD) is now thought to be the most common liver disease worldwide. Cardiovascular complications are a leading cause of mortality in NAFLD. Fructose, a common nutrient in the westernized diet, has been reported to be associated with increased cardiovascular risk, but its impact on adolescents with NAFLD is not well understood. We designed a 4-week randomized, controlled, double-blinded beverage intervention study. Twenty-four overweight Hispanic-American adolescents who had hepatic fat >8% on imaging and who were regular consumers of sweet beverages were enrolled and randomized to calorie-matched study-provided fructose only or glucose only beverages. After 4 weeks, there was no significant change in hepatic fat or body weight in either group. In the glucose beverage group there was significantly improved adipose insulin sensitivity, high sensitivity C-reactive protein (hs-CRP), and low-density lipoprotein (LDL) oxidation. These findings demonstrate that reduction of fructose improves several important factors related to cardiovascular disease despite a lack of measurable improvement in hepatic steatosis. Reducing dietary fructose may be an effective intervention to blunt atherosclerosis progression among NAFLD patients and should be evaluated in longer term clinical trials.

KW - Cardiovascular risk

KW - Children and adolescents

KW - Fructose

KW - Hepatic steatosis

KW - Nonalcoholic fatty liver disease

KW - Obesity

KW - Sugar

UR - http://www.scopus.com/inward/record.url?scp=84905924273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905924273&partnerID=8YFLogxK

U2 - 10.3390/nu6083187

DO - 10.3390/nu6083187

M3 - Article

VL - 6

SP - 3187

EP - 3201

JO - Nutrients

JF - Nutrients

SN - 2072-6643

IS - 8

ER -